Prestige Consumer Healthcare Inc. (PBH) Earnings Call Transcripts

116 earnings calls from January 2020 to September 10, 2026

NYSE US Health Care Pharmaceuticals

Prestige Consumer Healthcare Inc.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, Premium Brands Holdings Corporation (PBH:CA) reported revenues of $1.5 billion, reflecting a strong organic growth trajectory, although management acknowledged delays in promotional events and new product launches that could impact future sales. Earnings per share (EPS) were $0.75, which was inline with expectations. Management maintained guidance for high single-digit organic volume growth for the Specialty Foods segment, despite pushing some growth into the latter half of the year due to timing issues. The company remains optimistic about its pipeline of limited-time offers (LTOs) and overall market positioning, indicating potential for continued growth.

Reported metrics

MetricValueContext
Revenue $1.5B (beat) vs $1.45B est, +9% YoY
EPS $0.75 (inline) inline with expectations
Organic Volume Growth High single digits (negative) previously expected around 10%, now pushed into Q3 and Q4
CapEx Budget $55M (neutral) for larger projects over the next 4 quarters
Free Cash Flow Positive net free cash flow (positive) first time in 5 years, excluding Stampede impact
Specialty Foods Margin Target 13% to 14% (positive) expected to be reached by end of 2027

Guidance from management

Management maintained guidance for high single-digit organic volume growth in the Specialty Foods segment, with expectations for some growth to be realized in Q3 and Q4 due to delays in promotional activities.

What management said

Thank you, Joanna. Good morning, and welcome, everyone, to our 2026 First Quarter Conference Call. With me here today is our CFO, Will Kalutycz. Hopefully, you've had a chance to listen to our prerecorded remarks posted on our website this morning. We will now take your questions. Joanna?
— George Paleologou, Q1 FY2026 earnings call
Oh, yes, yes, absolutely. That -- those are just a wide -- we've got over 110 plants in the system. And they're always adding a line or doing improvement to a line to increase efficiency, those types of projects are constantly ongoing. We're always looking to improve the plants refined capacity, and that's just part of that. But we do consider it project CapEx because all of these smaller projects, they are smaller p...
— Will Kalutycz, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the impact of delayed promotions on future sales growth and the potential for inflation to affect margins. There were also questions about the sustainability of free cash flow improvements and the timeline for achieving targeted EBITDA margins.

Main topics on the call

Read the full Prestige Consumer Healthcare Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. (PBH) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 116 calls on record spanning January 30, 2020 to September 10, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 116 Prestige Consumer Healthcare Inc. earnings call transcripts on record, spanning January 30, 2020 to September 10, 2026. Based on this history, Prestige Consumer Healthcare Inc. reports quarterly. The most recent call on file is dated September 10, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
PBH
Exchange
NYSE
Country
US
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
116
First call
January 30, 2020
Most recent
September 10, 2026
Reporting cadence
quarterly
Quarter Date
Company Conference Presentations Sep 10, 2026 Read transcript →
Shareholder/Analyst Calls Aug 25, 2026 Read transcript →
Q2 FY2026 Aug 6, 2026 Read transcript →
Q1 FY2027 Aug 6, 2026 Read transcript →
Q2 FY2026 Aug 6, 2026 Read transcript →
Q4 FY2026 May 14, 2026 Read transcript →
Q1 FY2026 May 7, 2026 Read transcript →
Q1 FY2026 May 7, 2026 Read transcript →
Shareholder/Analyst Calls May 6, 2026 Read transcript →
M&A Calls Mar 20, 2026 Read transcript →
Q4 FY2025 Mar 19, 2026 Read transcript →
Q4 FY2025 Mar 19, 2026 Read transcript →
Q3 FY2026 Feb 5, 2026 Read transcript →
Q3 FY2025 Nov 10, 2025 Read transcript →
Q3 FY2025 Nov 10, 2025 Read transcript →
Q2 FY2026 Nov 6, 2025 Read transcript →
Earnings Calls Aug 29, 2025 Read transcript →
Q1 FY2026 Aug 7, 2025 Read transcript →
Q2 FY2025 Aug 6, 2025 Read transcript →
Q2 FY2025 Aug 6, 2025 Read transcript →
Q4 FY2025 May 8, 2025 Read transcript →
Q4 FY2024 Mar 21, 2025 Read transcript →
Earnings Calls Feb 25, 2025 Read transcript →
Q3 FY2025 Feb 6, 2025 Read transcript →
Company Conference Presentations Jan 14, 2025 Read transcript →
Shareholder/Analyst Calls Nov 11, 2024 Read transcript →
Q2 FY2025 Nov 7, 2024 Read transcript →
Q3 FY2024 Nov 6, 2024 Read transcript →
Q3 FY2024 Nov 6, 2024 Read transcript →
Q1 FY2025 Oct 30, 2024 Read transcript →
Company Conference Presentations Sep 5, 2024 Read transcript →
Earnings Calls Aug 22, 2024 Read transcript →
Q2 FY2024 Aug 8, 2024 Read transcript →
Q1 FY2025 Aug 8, 2024 Read transcript →
Q2 FY2024 Aug 8, 2024 Read transcript →
Q4 FY2024 Jul 31, 2024 Read transcript →
Q4 FY2024 May 15, 2024 Read transcript →
Q1 FY2024 May 13, 2024 Read transcript →
Q1 FY2024 May 13, 2024 Read transcript →
Shareholder/Analyst Calls May 10, 2024 Read transcript →
Q3 FY2024 Apr 24, 2024 Read transcript →
Q4 FY2023 Mar 15, 2024 Read transcript →
Q4 FY2023 Mar 15, 2024 Read transcript →
Q2 FY2024 Feb 25, 2024 Read transcript →
Q3 FY2024 Feb 8, 2024 Read transcript →
Q2 FY2024 Jan 30, 2024 Read transcript →
Shareholder/Analyst Calls Nov 27, 2023 Read transcript →
Q3 FY2023 Nov 14, 2023 Read transcript →
Q3 FY2023 Nov 14, 2023 Read transcript →
Q2 FY2024 Nov 2, 2023 Read transcript →
Q1 FY2024 Oct 24, 2023 Read transcript →
Company Conference Presentations Sep 7, 2023 Read transcript →
Earnings Calls Aug 31, 2023 Read transcript →
Shareholder/Analyst Calls Aug 29, 2023 Read transcript →
Q2 FY2023 Aug 14, 2023 Read transcript →
Q2 FY2023 Aug 14, 2023 Read transcript →
Q1 FY2024 Aug 3, 2023 Read transcript →
Q4 FY2023 Jul 28, 2023 Read transcript →
Shareholder/Analyst Calls Jun 30, 2023 Read transcript →
Q1 FY2023 May 15, 2023 Read transcript →
Q4 FY2023 May 4, 2023 Read transcript →
Q3 FY2023 Apr 28, 2023 Read transcript →
Q4 FY2022 Mar 16, 2023 Read transcript →
Earnings Calls Feb 27, 2023 Read transcript →
Q3 FY2023 Feb 2, 2023 Read transcript →
Q2 FY2023 Jan 30, 2023 Read transcript →
Q3 FY2022 Nov 3, 2022 Read transcript →
Q2 FY2023 Nov 3, 2022 Read transcript →
Q1 FY2023 Oct 24, 2022 Read transcript →
Shareholder/Analyst Calls Oct 20, 2022 Read transcript →
Earnings Calls Aug 31, 2022 Read transcript →
Q2 FY2022 Aug 5, 2022 Read transcript →
Q1 FY2023 Aug 4, 2022 Read transcript →
Q4 FY2022 Jul 29, 2022 Read transcript →
Q1 FY2022 May 6, 2022 Read transcript →
Q4 FY2022 May 6, 2022 Read transcript →
Shareholder/Analyst Calls May 5, 2022 Read transcript →
Q3 FY2022 Apr 29, 2022 Read transcript →
Q4 FY2021 Mar 10, 2022 Read transcript →
Earnings Calls Feb 24, 2022 Read transcript →
Q3 FY2022 Feb 3, 2022 Read transcript →
Q2 FY2022 Jan 27, 2022 Read transcript →
Company Conference Presentations Dec 2, 2021 Read transcript →
Q3 FY2021 Nov 4, 2021 Read transcript →
Q2 FY2022 Nov 4, 2021 Read transcript →
Q1 FY2022 Oct 27, 2021 Read transcript →
Shareholder/Analyst Calls Oct 5, 2021 Read transcript →
Earnings Calls Aug 31, 2021 Read transcript →
Q2 FY2021 Aug 5, 2021 Read transcript →
Q1 FY2022 Aug 5, 2021 Read transcript →
Q4 FY2021 Jul 29, 2021 Read transcript →
Q1 FY2021 May 6, 2021 Read transcript →
Q4 FY2021 May 6, 2021 Read transcript →
Shareholder/Analyst Calls May 5, 2021 Read transcript →
Q3 FY2021 Apr 30, 2021 Read transcript →
Q4 FY2020 Mar 11, 2021 Read transcript →
Earnings Calls Feb 24, 2021 Read transcript →
Q3 FY2021 Feb 4, 2021 Read transcript →
Q2 FY2021 Jan 28, 2021 Read transcript →
Shareholder/Analyst Calls Nov 17, 2020 Read transcript →
Q3 FY2020 Nov 5, 2020 Read transcript →
Q2 FY2021 Nov 5, 2020 Read transcript →
Q1 FY2021 Oct 26, 2020 Read transcript →
Earnings Calls Aug 27, 2020 Read transcript →
Q2 FY2020 Aug 6, 2020 Read transcript →
Q1 FY2021 Aug 6, 2020 Read transcript →
Shareholder/Analyst Calls Aug 3, 2020 Read transcript →
Q4 FY2020 Jul 27, 2020 Read transcript →
Q1 FY2020 May 11, 2020 Read transcript →
Shareholder/Analyst Calls May 8, 2020 Read transcript →
Q4 FY2020 May 7, 2020 Read transcript →
Q3 FY2020 Apr 28, 2020 Read transcript →
Q4 FY2019 Mar 12, 2020 Read transcript →
Earnings Calls Feb 26, 2020 Read transcript →
Q3 FY2020 Feb 6, 2020 Read transcript →
Q2 FY2020 Jan 30, 2020 Read transcript →